- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05750862
Accuracy of Topography Guided Automatic Marking of the Intraocular Lens (IOL) -Axis
Accuracy of Topography Guided Automatic Marking of the Intraocular Lens (IOL) -Axis in Toric IOL-impantation in Femtosecond Laser Assisted Cataract Surgery (FLACS). A Prospective Non-randomised Controlled Study
In cataract surgery, the opaque lens is replaced by an artificial intraocular lens. The procedure also allows for correction of an refractive error such as myopia, hyperopia or astigmatism. In case of correction of an astigmatism, the axis intraocular lens has to be alligned to the axis of the corneal astigmatism. There are serveral options, the intendet position of the axis can be marked on the cornea, either manually using ink and a special caliper or with an automatic laser device.
The aim of this study is to assess the accuracy of topography guided automatic marking of the intended IOL-axis in toric IOL-implantation in femtosecond laser assisted cataract surgery (FLACS)
Study Overview
Status
Conditions
Detailed Description
In cataract surgery, the opaque lens is replaced by an artificial intraocular lens. Based on a preoperative measurement of the eye (biometry) the power of the artificial lens is calculated so that refractive errors may be corrected. If high corneal astigmatism is present a correction of this astigmatism is also possible and offered to the patients. This may lead to a certain degree of spectacle independence. The astigmatism is corrected by the implantation of a special toric lens (spherical and cylindrical correction). This toric lens has to be positioned in the eye so that the axis of the IOL-cylinder aligns 90° to the axis of the corneal cylinder. The axis of the corneal cylinder has to be measured and marked before the intervention. Usually, the intended axis of placement for the toric IOL is marked with ink at the slitlamp or with the aid of a manual axis instrument. Anatomical landmarks without preoperative marking are also used. A clinical trends survey of the European society of cataract and refractive surgery (ESCRS) for 2021 has revealed that in 15% of all cataract cases (totally 550'000 cases assessed) a special toric IOL was implanted to correct a clinically significant astigmatism. About 75% use manual marking with ink. Only 25% of cases were operated using a digital image registration.
The manual marking using a marking device is currently the gold standard. However, the manual marking might be not very precise. The thick ink-marks on the cornea and the limbus are not very well visible. Sometimes the marks are not perfectly centred on the optical axis of the eye. Head tilt and rotation of the eyeball if patients are not fixating may lead to a deviation up to several degrees.
One possible solution of this problem are digital imaging technologies. The Cassini topography instrument for example provides additional to the measurement of the axis and the cylindrical power of the cornea a digital image of the iris. If the cataract surgery is performed assisted by a femtosecond laser (FLACS), this digital image is transferred to the femtosecond laser. Based on this image the software of the laser is capable to determine the correct position of the axis of the cylinder of the cornea and the femtosecond laser can make two intrastromal marks in the cornea. These marks allow the surgeon to align the toric IOL without any preoperative manipulations with ink and marking tools.
The aim of this study is to assess the accuracy of topography guided automatic marking of the intended IOL-axis in toric IOL-implantation in femtosecond laser assisted cataract surgery (FLACS)
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lucerne, Switzerland, 6000
- Eye Clinic, Cantonal Hospital of Lucerne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients scheduled for cataract surgery who opt for a femtolaser-assisted cataract surgery (FLACS) and Implantation of a toric intraocular lens. (both are extra options not covered by the insurance)
- Corneal astigmatism more than 1.o diopters confirmed in a measurement of corneal topography (Pentacam and Cassini topography devices)
Exclusion Criteria:
- Earlier corneal or intraocular refractive interventions (C-TEN, Lasik…)
- Irregular corneal astigmatism
- Corneal pathologies associated with ectasia and/or irregular astigmatism (Pterygium, Keratoconus, pellucide marginal degeneration…)
- Earlier intraocular or ocular surface involving surgeries
- Severe dry eye disease
- Contraindication of performing cataract surgery under topical anaesthesia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Intervention arm
Study with one single arm.
All participants will receive two interventions that will be compared to each other.
|
The marking of the intended implantation axis of the interocular lens will be marked in all patients with topography guided in the corneal stroma with laser and in addition manually with a caliper and ink on the corneal surface
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Deviation of laser marking
Time Frame: 1 month
|
Deviation of laser marking in the cornea compared to intended position of the axis in degrees
|
1 month
|
|
Difference of laser marking
Time Frame: 1 month
|
Difference of laser marking in the cornea compared to manual ink marking in degrees.
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction of astigmatism
Time Frame: 1 month
|
Total of reduction of astigmatism in the postoperative refraction
|
1 month
|
|
Decentration of manual ink marking
Time Frame: 1 month
|
Decentration of the ink marking (yes or no)
|
1 month
|
|
correction of IOL position
Time Frame: 1 month
|
Number of necessary corrections of IOL-position
|
1 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Frank Bochmann, MD, Eye Clinic, Cantonal Hospital of Lucerne, Switzerland
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023_D0001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract Senile
-
Carl Zeiss Meditec AGCompleted
-
Johannes Kepler University of LinzWithdrawn
-
AST Products, Inc.Completed
-
Carl Zeiss Meditec AGCompleted
-
Vienna Institute for Research in Ocular SurgeryCompleted
-
Carl Zeiss Meditec AGCompleted
-
Carl Zeiss Meditec AGCompleted
-
Akdeniz UniversityCompleted
-
Peking University Third HospitalUnknown
Clinical Trials on Marking of the intended axis of IOL-Implantation manually with an ink and marking device on the surface of the eye
-
Abbott Medical DevicesCompletedThe Patient Meets ACC/AHA/ESC Guidelines for Implantable Cardioverter Defibrillator (ICD) or Cardiac Resynchronization Therapy (CRT-D) DeviceUnited Kingdom, Germany
-
Centre Hospitalier Universitaire de NīmesCHU Arnaud de Villeneuve MONTPELLIERRecruiting
-
University of AlicanteCompletedSports Physical Therapy | Antioxidative Stress | Nutritional Disorder | Female Athlete Triad | Mediterranean Diet | Energy Deficit Syndrome | Red FruitsSpain
-
Mansoura UniversityActive, not recruiting
-
Centre Hospitalier de CayenneEuropean Regional Development FundRecruitingChildren | Dengue Fever | AdultsFrance
-
Istituto Clinico HumanitasUnknown
-
BonusBio Group LtdCompletedBone Void in the Maxillofacial AreaIsrael
-
Memorial Sloan Kettering Cancer CenterPfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of VirginiaCompletedNeurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial HemangiopericytomaUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); ITI International Team for Implantology... and other collaboratorsActive, not recruitingEdentulous Mouth | Tooth-loss | Complete Denture | Complete Lower DentureCanada